tiprankstipranks
Cyanotech Corp. (CYAN)
OTHER OTC:CYAN
US Market

Cyanotech (CYAN) Price & Analysis

Compare
74 Followers

CYAN Stock Chart & Stats


---

Financials

Quarterly

Ownership Overview

32.57%1.58%65.85%
32.57% Insiders
1.58% Other Institutional Investors
65.85% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

CYAN FAQ

What was Cyanotech Corp.’s price range in the past 12 months?
Cyanotech Corp. lowest stock price was $0.25 and its highest was $0.89 in the past 12 months.
    What is Cyanotech Corp.’s market cap?
    Cyanotech Corp.’s market cap is $2.58M.
      When is Cyanotech Corp.’s upcoming earnings report date?
      Cyanotech Corp.’s upcoming earnings report date is Jul 01, 2025 which is in 127 days.
        How were Cyanotech Corp.’s earnings last quarter?
        Cyanotech Corp. released its earnings results on Feb 11, 2025. The company reported -$0.031 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.031.
          Is Cyanotech Corp. overvalued?
          According to Wall Street analysts Cyanotech Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Cyanotech Corp. pay dividends?
            Cyanotech Corp. does not currently pay dividends.
            What is Cyanotech Corp.’s EPS estimate?
            Cyanotech Corp.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cyanotech Corp. have?
            Cyanotech Corp. has 7,155,858 shares outstanding.
              What happened to Cyanotech Corp.’s price movement after its last earnings report?
              Cyanotech Corp. reported an EPS of -$0.031 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.
                Which hedge fund is a major shareholder of Cyanotech Corp.?
                Currently, no hedge funds are holding shares in CYAN
                ---

                Company Description

                Cyanotech Corp.

                Cyanotech Corp. engages in the development and commercialization of natural products derived from microalgae. Its products include BioAstin natural astaxanthin, a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health; and Spirulina Pacifica, a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Alico
                Nature's Sunshine Products
                Chromadex
                Hemp
                Kali
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis